Sensitive method for the quantification of urinary pyrimidine metabolites in healthy adults by gas chromatography-tandem mass spectrometry

被引:14
作者
Hofmann, U
Schwab, M
Seefried, S
Marx, C
Zanger, UM
Eichelbaum, M
Mürdter, TE
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] Univ Tubingen, Div Clin Pharmacol, D-72076 Tubingen, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 791卷 / 1-2期
关键词
pyrimidine;
D O I
10.1016/S1570-0232(03)00251-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil. To assess whether urinary levels of pyrimidines and their metabolites can be used for predicting patients' individual phenotype, a new gas chromatographic-tandem mass spectrometric method was developed which allows the simultaneous determination of uracil and thymine and their metabolites dihydrouracil, dihydrothymine, beta-ureidopropionic acid, beta-ureidoisobutyric acid, and the amino acids beta-alanine and beta-aminoisobutyric acid in human urine. Small aliquots (2-20 mul) of the urine samples were evaporated and derivatized to the tert.-butyldimethylsilyl derivatives before quantification, using the respective stable isotope-labelled analogues as internal standards. Analytical variation was acceptable with an intra-day imprecision (RSD) below 10%, for beta-ureidoisobutyric acid below 15%. The method was used for investigating the stability of urine samples and the influence of urine collection at different times. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 19 条
[1]   DETERMINATION OF CREATININE-RELATED URINARY URACIL EXCRETION IN CHILDREN BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ASSMANN, B ;
HAAS, HJ .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 525 (02) :277-285
[2]  
HARRIS BE, 1990, CANCER RES, V50, P197
[3]  
Hayashi K, 1996, CLIN CANCER RES, V2, P1937
[4]   Syntheses of 2H-labelled dihydropyrimidinediones and their metabolites [J].
Heinkele, G ;
Hofmann, U ;
Opitz, J ;
Mürdter, TE .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2001, 44 (01) :7-11
[5]   Screening for pyrimidine metabolism disorders using dried filter-paper urine samples: Method development and a pilot study in Nagoya City, Japan [J].
Imaeda, M ;
Sumi, S ;
Ohba, S ;
Kidouchi, K ;
Kodama, K ;
Fujimoto, S ;
Togari, H ;
Wada, Y .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 190 (01) :23-32
[6]  
Ito T, 2000, CLIN CHEM, V46, P445
[7]   Simple gas chromatographic-mass spectrometric procedure for diagnosing pyrimidine degradation defects for prevention of severe anticancer side effects [J].
Kuhara, T ;
Ohdoi, C ;
Ohse, M .
JOURNAL OF CHROMATOGRAPHY B, 2001, 758 (01) :61-74
[8]  
LU ZH, 1993, CANCER RES, V53, P5433
[9]   Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity [J].
Milano, G ;
Etienne, MC ;
Pierrefite, V ;
Barberi-Heyob, M ;
Deporte-Fety, R ;
Renée, N .
BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) :627-630
[10]   Screening and diagnosis of β-ureidopropionase deficiency by gas chromatographic mass spectrometric analysis of urine [J].
Ohse, M ;
Matsuo, M ;
Ishida, A ;
Kuhara, T .
JOURNAL OF MASS SPECTROMETRY, 2002, 37 (09) :954-962